Clofazimine
- 1 March 1976
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 112 (3) , 344-349
- https://doi.org/10.1001/archderm.1976.01630270024006
Abstract
• Eight patients had pyoderma gangrenosum. They were given a phendimetrazine tartrate derivative, clofazimine (Lamprene [Britain]), which is a chemotherapeutic agent used mainly in certain mycobacterial infections and which also has phagocytosis-enhancing properties. The effect of this drug was remarkably good, with rapid healing of the lesions commencing 3 to 14 days after treatment was started. The mechanism for the effect of clofazimine in pyoderma gangrenosum is not known. (Arch Dermatol 112:344-349, 1976)Keywords
This publication has 5 references indexed in Scilit:
- PYODERMA GANGRENOSUM WITH ALTERED CELLULAR IMMUNITY AND DERMONECROTIC FACTOR*British Journal of Dermatology, 1972
- Enhancing Effect of Clofazimine (B663) on the Phagocytosis of Neutrophilic Leucocytes in VitroScandinavian Journal of Haematology, 1971
- The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activityJournal of Clinical Investigation, 1970
- Inter-Relations between Adrenocortical Functions and Infectious IllnessNew England Journal of Medicine, 1969
- The Experimental Properties of G 30 320 (B 663) - a New Anti-leprotic AgentLeprosy Review, 1969